INTRODUCTION Cirrhosis of the liver is a chronic disease that is widespread and irreversible. It represents the fi nal stage of numerous diseases that affect the liver. By the end of 2017, it was the 11th most common cause of death, with a loss of 41.
View Article and Find Full Text PDFThis study was conduced to determinate the seroprevalence and risk factors associated to hepatitis E virus (HEV) exposition, in individuals who work in pig farms located at western of Artemise Province. The presence of HEV in human and swine samples and the phylogenetic analysis were evaluated. One hundred six workers (with an age range of 18-70years) were enrolled in this study.
View Article and Find Full Text PDFIntroduction: the protective efficacy follow-up studies in high risk groups for hepatitis B virus infection, which were inoculated with recombinant hepatitis B vaccines, are limited and the duration of protection is yet to be determined in those vaccinated people.
Objectives: to determine the protective efficacy of Heberbiovac HB vaccine at different dosage in physically and mentally-handicapped children after 14 years of the primary vaccination schedule.
Methods: in 1991, an effectiveness study of vaccine Heberbiovac HB was conducted in 2 groups of physically and mentally-handicapped (A = 10 microg y B = 5 microg).